The University of Chicago Header Logo

Connection

Ravi Salgia to Clinical Trials, Phase II as Topic

Back to Details
This is a "connection" page, showing publications Ravi Salgia has written about Clinical Trials, Phase II as Topic.
Ravi Salgia
Connection Strength
0.201
Clinical Trials, Phase II as Topic
  1. Evidence-based role of bevacizumab in non-small cell lung cancer. Ann Oncol. 2013 Jan; 24(1):6-9.
    View in: PubMed
    Score: 0.104
  2. Durable complete response of metastatic gastric cancer with anti-Met therapy followed by resistance at recurrence. Cancer Discov. 2011 Dec; 1(7):573-9.
    View in: PubMed
    Score: 0.097
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.